Glass Pharms has received the funding needed to build what it calls the first medical cannabis facility to be carbon-negative.
Story continues below
This advertisement has not loaded yet, but your article continues below.
In a deal with an unnamed infrastructure investment fund, Glass Pharms notes it will get up to £22.5 million ($38.5 million) “in financing to build the first dedicated medical cannabis cultivation facility that will be carbon negative by design.”
An area in the South of England will serve as the home for the planned 2.5-hectare greenhouse facility, notes a company statement.
Glass Pharms, which snagged the first U.K. commercial licence to supply high-THC cannabis flower to lawful third parties, like pharmaceutical companies, explains that the
Read full article on The Growth Op
